Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE
Wolfgang Pronai, Alexander R. Rosenkranz(Medical University of Graz), Ursula Barnas(University of Vienna), Clemens Wieser(Department of Education), Ulrich Neyer(Vorarlberg Institute for Vascular Investigation and Treatment), Margit Hemetsberger, Christine Jaeger, Daniel Dekic
Cited by 1
Related Papers
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis Patients
|Journal of the American Society of Nephrology|2000|125
Intravenous calcitriol normalizes insulin sensitivity in uremic patients
|Kidney International|1995|92
Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control
|Diabetologia|1997|65
Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead.
|Occupational and Environmental Medicine|1999|44